A randomised study comparing granulocyte-coiony stimulating factor (G-CSF) with G-CSF plus thymostimulin in the treatment of haematological toxicity in patients with advanced breast cancer after high dose mitoxantrone therapy
- 31 January 1996
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 32 (1) , 52-56
- https://doi.org/10.1016/0959-8049(95)00459-9
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- In Vivo Effects of Thymustimulin on Hematopoiesis of Mice Treated with CyclophosphamideClinical Immunology and Immunopathology, 1993
- Can hematopoietic growth factors be used to improve the success of cytotoxic chemotherapy?Anti-Cancer Drugs, 1993
- Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapyEuropean Journal Of Cancer, 1993
- Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: a randomized controlled trialBlood, 1992
- Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung CancerNew England Journal of Medicine, 1991
- Modulation of NK activity by thymic hormones:in vitro effects of thymostimulinMedical Oncology and Tumor Pharmacotherapy, 1989
- Thein vitro effect of a calf thymus extract (thymostimulin) on the immunologic parameters of patients with untreated Hodgkin's diseaseCancer, 1982
- Reporting results of cancer treatmentCancer, 1981
- Enhancement of the immune system of chemotherapy-treated cancer patients by simultaneous treatment with thymic extract, TP-1Cancer Immunology, Immunotherapy, 1980
- An analysis of variance test for normality (complete samples)Biometrika, 1965